References
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63. doi: 10.3322/caac.21834
- Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27: 1386-422. doi: 10.1093/annonc/mdw235
- Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009; 27: 3677-83. doi: 10.1200/JCO.2008.20.5278
- Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-9. doi: 10.1097/01.sla.0000217629.94941.cf
- Aykut B, Lidsky ME. Colorectal cancer liver metastases: multimodal therapy. Surg Oncol Clin N Am 2023; 32: 119-41. doi: 10.1016/j.soc.2022.07.009
- Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases – a population-based study on incidence, management and survival. BMC Cancer 2018; 18: 78. doi: 10.1186/s12885-017-3925-x
- Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-25; discussion 25-7. doi: 10.1097/01. sla.0000128305.90650.71
- Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-9. doi: 10.1002/hep.21933
- Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, et al. percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes – a 10-year experience at a single center. Radiology 2016; 278: 601-11. doi: 10.1148/radiol.2015142489
- House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010; 210: 744-52, 52-5. doi: 10.1016/j.jamcollsurg.2009.12.040
- van der Lei S, Puijk RS, Dijkstra M, Schulz HH, Vos DJW, De Vries JJJ, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol 2025; 26: 187-99. doi: 10.1016/s1470-2045(25)00716-8
- Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg 2018; 267: 132-41. doi: 10.1097/SLA.0000000000002064
- Peng J, Liu Y, Li W, Lin Y, Sun H, Pan Z, et al. Application of tumor burden score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy. Therap Adv Gastroenterol 2021; 14: 17562848211066206. doi: 10.1177/17562848211066206
- Hahn F, Müller L, Stöhr F, Mähringer-Kunz A, Schotten S, Düber C, et al. The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: prognostic marker or hyped parameter? Liver Int 2019; 39: 1307-14. doi: 10.1111/liv.14132
- Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29(Suppl 2): ii1-9. doi: 10.1093/annonc/mdx810
- Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997-1006. doi: 10.1139/H08-075
- Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012; 30: 1323-41. doi: 10.1016/j. mri.2012.05.001
- Manabe T, Ogawa C, Takuma K, Nakahara M, Oura K, Tadokoro T, et al. Usefulness of the measurement of psoas muscle volume for sarcopenia diagnosis in patients with liver disease. Diagnostics (Basel) 2023; 13: doi: 10.3390/diagnostics13071245
- Wasserthal J, Breit HC, Meyer MT, Pradella M, Hinck D, Sauter AW, et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol Artif Intell 2023; 5: e230024. doi: 10.1148/ryai.230024
- Castillo-López JA, Bravo-Ontiveros F, Rodea-Montero ER. Identification of bone mineral density deficit using L1 trabecular attenuation by opportunistic multidetector CT scan in adult patients. Tomography 2023; 9: 150-61. doi: 10.3390/tomography9010013
- Müller L, Mähringer-Kunz A, Auer TA, Fehrenbach U, Gebauer B, Haubold J, et al. Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study. Eur Radiol 2023; 33: 1031-9. doi: 10.1007/s00330-022-09069-8
- Gurusamy P, Larsen BA, Allen RT, Ward SR, Allison MA, Hughes-Austin JM. Density and fat fraction of the psoas, paraspinal, and oblique muscle groups are associated with lumbar vertebral bone mineral density in a multi-ethnic community-living population: the multi-ethnic study of atherosclerosis. J Bone Miner Res 2022; 37: 1537-44. doi: 10.1002/jbmr.4634
- Huang CB, Lin DD, Huang JQ, Hu W. Based on CT at the third lumbar spine level, the skeletal muscle index and psoas muscle index can predict osteoporosis. BMC Musculoskelet Disord 2022; 23: 933. doi: 10.1186/s12891-022-05887-5
- Qiu ZC, Li C, Zhang Y, Xie F, Yu Y, Leng SS, et al. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection. Langenbecks Arch Surg 2023; 408: 250. doi: 10.1007/s00423-023-02993-3
- Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology 2014; 273: 241-60. doi: 10.1148/radiol.14132958
- Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011; 13: 43946. doi: 10.1111/j.1477-2574.2011.00301.x
- Imai K, Takai K, Aiba M, Unome S, Miwa T, Hanai T, et al. Psoas muscle index as an independent predictor of survival in patients with hepatocellular carcinoma receiving systemic targeted therapy. Cancers (Basel) 2025; 17: 209. doi: 10.3390/cancers17020209
- Kamada T, Furukawa K, Takahashi J, Nakashima K, Nakaseko Y, Suzuki N, et al. Prognostic significance of osteopenia in patients with colorectal cancer: a retrospective cohort study. Ann Gastroenterol Surg 2021; 5: 832-43. doi: 10.1002/ags3.12491
- Matsubara Y, Nakamura K, Matsuoka H, Ogawa C, Masuyama H. Pretreatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer. Mol Clin Oncol 2019; 11: 376-82. doi: 10.3892/mco.2019.1912
- Jennings SG, Winer-Muram HT, Tarver RD, Farber MO. Lung tumor growth: assessment with CT--comparison of diameter and cross-sectional area with volume measurements. Radiology 2004; 231: 866-71. doi: 10.1148/radiol.2313030715
- Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer 2016; 57: 58-67. doi: 10.1016/j.ejca.2015.12.030